fashion -WSS

fashion

author：leisure time 2025-08-23 05:01:00 - browse：8

Adam's take main illustration — Molly Ferguson/STAT

Have you heard the news? I’m launching a weekly email newsletter starting on March 28. It’s called Adam’s Biotech Scorecard and it’s exclusively for STAT subscribers. One catch: We need you to sign up, which you can do here. What should you expect to see in my newsletter each week? Unfiltered, uncompromising, and (hopefully) valuable insight and analysis from the intersection of Wall Street and biotech. Plus, a few dashes of fun.

In other words, a lot like the content below. I’m really excited to get started and I hope you’ll find the newsletter worthy of your inbox real estate.

This week: A deep dive into the bull and bear sides of the Applied Therapeutics debate, and another well-deserved swipe at Cassava Sciences and its entirely ridiculous Alzheimer’s drug candidate.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： An exit interview with Bristol Myers Squibb CEO Giovanni Caforio

entertainment

WSS

Meta's Zuckerberg and Chan on track to put $50 billion into science

Medicare bonuses could stop drug shortages under Senate plan

Flu vaccine reformulation won't be easy, manufacturers warn

FDA has safety concerns on CRISPR

Traditional Chinese medicine benefits explored in new JAMA study

Paying for Covid pills will soon shift to insurers

explore

fashion

knowledge

Anesthesiologist group: stop taking Ozempic before surgery

The FDA weighs the risks of candy

Continuity nursing helped my family in our darkest PICU moments

STAT Wunderkinds: Ruey Hu's digital tools for parsing research

Drug repurposing or repositioning? The language matters

Head of FDA's diagnostics center, who led through Covid, retires

Virginia high school admissions case could be legal follow

Immunocompromised patients offer clues on chronic Covid

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Medicare bonuses could stop drug shortages under Senate plan

explore

Readout Newsletter: The latest from Bristol, Sarepta, and Novartis

Emergency medicine has repudiated 'excited delirium.' Now what?

Dana Farber says 6 studies to be retracted and 31 corrected

Physician subsidies by hospitals soar in wake of No Surprises Act

Paying for Covid pills will soon shift to insurers

Medicare drug price lawsuits could be good politics for Biden

entertainment

explore

explore

leisure time